| scholarly article | Q13442814 |
| P2093 | author name string | Ying Wang | |
| Andreas Schulze | |||
| Autar K Walli | |||
| Peter Fraunberger | |||
| Dietrich Seidel | |||
| Uwe Hasbargen | |||
| Christian Thaler | |||
| Frithjof Blessing | |||
| P2860 | cites work | Elevated soluble adhesion molecules in women with pre-eclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation | Q78202117 |
| Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis | Q28204187 | ||
| Management and monitoring of severe preeclampsia | Q34224924 | ||
| Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review | Q35169648 | ||
| Effect of intensive plasmapheresis on the plasma cholesterol concentration with familial hypercholesterolemia | Q40195984 | ||
| The efficacy and safety of the new heparin-induced extracorporeal low-density lipoprotein precipitation system (Plasmat Futura) in comparison with the currently used system (Plasmat Secura). | Q44884393 | ||
| Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins--reduction of circulating proinflammatory and procoagulatory markers | Q44928875 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Variations in practice and outcomes in the Canadian NICU network: 1996-1997. | Q50131813 | ||
| "Accelerated starvation" and the skipped breakfast in late normal pregnancy | Q51651574 | ||
| Low-density lipoprotein apheresis therapy during pregnancy | Q59692256 | ||
| The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HEL | Q68036473 | ||
| Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels | Q69242889 | ||
| Hyperlipoprotein(a)aemia in nephrotic syndrome | Q71328360 | ||
| The Abnormal Lipoprotein of Cholestasis | Q71796850 | ||
| Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption | Q71897699 | ||
| Pregnancy in a patient with homozygous familial hypercholesterolemia treated with long-term low-density lipoprotein apheresis | Q72184364 | ||
| Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis | Q73114832 | ||
| Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q73788745 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Elevated levels of lipoprotein(a) in women with preeclampsia | Q74182500 | ||
| Homocysteine and atherothrombosis | Q74424094 | ||
| Prevention of preeclampsia: a big disappointment | Q77580496 | ||
| P433 | issue | 2 | |
| P921 | main subject | maternal health | Q6786626 |
| lipoprotein | Q28350 | ||
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 103-110 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Transfusion and Apheresis Science | Q15758507 |
| P1476 | title | Heparin-mediated extracorporeal low density lipoprotein precipitation as a possible therapeutic approach in preeclampsia | |
| P478 | volume | 35 |
| Q45781215 | Double filtration plasmapheresis in different diseases in Thailand |
| Q34176440 | Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population. |
| Q83271300 | HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women |
| Q49058047 | Improved neuronal survival of focal ischemia after delipid extracorporeal lipoprotein treatment in hyperlipidemic rabbits |
| Q37033161 | Lipoprotein (a): impact by ethnicity and environmental and medical conditions |
| Q52355642 | Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study. |
| Q38239729 | Maternal lipids in pre-eclampsia: innocent bystander or culprit? |
| Q49159738 | New insights into mechanisms of glomerular injury and repair from the 10th International Podocyte Conference 2014. |
| Q34453242 | Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy |
| Q36043513 | Response to Plasmapheresis Measured by Angiogenic Factors in a Woman with Antiphospholipid Syndrome in Pregnancy |
| Q53402841 | Surface glycosylation of poly(3-hydroxybutyrate-co-4-hydroxybutyrate) membrane for selective adsorption of low-density lipoprotein. |
| Q26853473 | The current status of lipoprotein (a) in pregnancy: a literature review |
| Q38654145 | Therapeutic apheresis in pregnancy: General considerations and current practice |
| Q26998662 | Treatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold? |
| Q39152873 | Upcoming drugs for the treatment of preeclampsia in pregnant women |
| Q37022169 | What's going on in LDL apheresis |
Search more.